Cytocom, Inc.
CBLI · NASDAQ
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,946 | $1,126 | $3,617 | $4,231 |
| Short-Term Investments | $325 | $452 | $504 | $4,561 |
| Receivables | $12 | $379 | $252 | $554 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $32 | $45 | $103 | $234 |
| Total Curr. Assets | $2,314 | $2,003 | $4,476 | $9,580 |
| Property Plant & Equip (Net) | $4 | $16 | $28 | $19 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $19 | $30 | $31 |
| Total NC Assets | $4 | $34 | $58 | $49 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,318 | $2,037 | $4,534 | $9,629 |
| Liabilities | – | – | – | – |
| Payables | $168 | $264 | $139 | $201 |
| Short-Term Debt | $2,641 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | -$2,504 | $789 | $773 | $2,012 |
| Total Curr. Liab. | $305 | $1,053 | $912 | $2,213 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $8 | $7 |
| Total NC Liab. | $0 | $0 | $8 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $305 | $1,053 | $920 | $2,221 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $67 | $56 | $56 | $56 |
| Retained Earnings | -$169,104 | -$166,706 | -$164,059 | -$160,447 |
| AOCI | -$686 | -$1,000 | -$1,000 | -$1,000 |
| Other Equity | $171,736 | $168,633 | $168,616 | $168,799 |
| Total Equity | $2,013 | $984 | $3,614 | $7,408 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,318 | $2,037 | $4,534 | $9,629 |
| Net Debt | $695 | -$1,126 | -$3,617 | -$4,231 |